• OPEN AN ACCOUNT
Indian Indices
Sensex
73,561.89 -18.65
( -0.03%)
Global Indices
Nasdaq
51,370.81 -161.78
(-0.31%)
Dow Jones
7,725.73 -1.30
(-0.02%)
Hang Seng
66,308.10 794.11
(1.21%)
Nikkei 225
10,680.49 -24.77
(-0.23%)
Forex
USD-INR
95.73 0.08
(0.09%)
EUR-INR
109.20 -0.36
(-0.33%)
GBP-INR
127.12 -0.62
(-0.48%)
JPY-INR
0.61 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

mrf ltd
Concord Biotech's Unit II formulations unit successfully clears PPB and NDA inspection
Jun 25,2026
Concord Biotech announced the successful completion of inspection by the Pharmacy and Poisons Board (PPB) from Kenya and the National Drug Authority (NDA) from Uganda at Unit-II formulation facility. The inspection took place from 18 June 2026 to 24 June 2026, and was concluded successfully.